TTrialPathMatch Me to Trials
← Back to trials
RecruitingChin Augmentation

Study to Evaluate the Safety of Retreatment With Restylane® Lyft With Lidocaine for Augmentation of the Chin Region

Eligible age

22+ yrs

Accepts

All genders

Locations

6 states

Healthy volunteers

Yes

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The primary objective of this study is to evaluate the safety of Restylane Lyft with Lidocaine for augmentation of the chin region 3 months after retreatment.

Sponsor: Galderma R&D

You may qualify if…

  • ✓ 1. Males or non-pregnant, non-breastfeeding females, 22 years of age or older.
  • ✓ 2. Intent to receive treatment for augmentation and correction of retrusion in the chin region.

You may not qualify if…

  • ✕ 1. Known/previous allergy or hypersensitivity to any injectable hyaluronic acid (HA) gel or to gram positive bacterial proteins.
  • ✕ 2. Known/previous allergy or hypersensitivity to local anesthetics, e.g. lidocaine or other amide-type anesthetics.
  • ✕ 3. Previous or present multiple allergies or severe allergies, such as manifested by anaphylaxis or angioedema, or family history of these conditions.
  • ✕ 4. Previous facial surgery (including facial aesthetic surgery and liposuction), below the level of the horizontal line from subnasale.
  • ✕ 5. Any previous aesthetic procedures or implants.
  • ✕ 6. Presence of any disease or lesions near or on the area to be treated.

Where it's recruiting

Connecticut

Westport

Florida

Boynton Beach · Coral Gables

Georgia

Atlanta

Maryland

Bethesda

Tennessee

Nashville

Texas

Spring

Source: ClinicalTrials.gov · NCT07566286 · last updated 2026-08-14